Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lersivirine vs Efavirenz in Treatment-Naive HIV-1 Patients
NCT00824421Phase 2Completed
- Sponsor
- Pfizer
- Start
- Feb 2009
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of lersivirine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Pfizer. Started Feb 2009; status: completed.
02
Drugs
lersivirine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00824421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00824421.